Skip to main content
logo
Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
78.08
-1.72 (-2.16%)
At close: Aug 28, 2026, 4:00 PM EDT
79.63
+1.55 (1.99%)
After-hours: Aug 28, 2026, 7:49 PM EDT

KNSA Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
80.6659.01-43.1914.08183.36-157.92
Depreciation & Amortization
1.791.551.72.342.42.36
Loss (Gain) From Sale of Assets
-0.13-0.12-0.020.180.030.1
Loss (Gain) From Sale of Investments
1.07-0.920.44-1.07-0.080.66
Stock-Based Compensation
42.073730.6927.1525.1225.17
Other Operating Activities
18.4616.6711.27-30.73-182.452.64
Change in Accounts Receivable
8.4226.13-20.46-0.95-16.33-3.91
Change in Inventory
-22.75-28.534.76-9.52-17.92-3.68
Change in Accounts Payable
3.420.14-6.310.356.031.37
Change in Unearned Revenue
--19.550.2612-
Change in Other Net Operating Assets
51.9627.0527.2711.22-6.356.91
Operating Cash Flow
184.97137.9925.6913.35.81-126.3
Operating Cash Flow Growth
176.28%437.14%93.14%129.05%--

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-2.13-1.57-0.28-0.13-0.11-0.42
Sale of Property, Plant & Equipment
--0.03-0.09-
Sale (Purchase) of Intangibles
------20
Investment in Securities
-236.94-187.4337.92-29.43-8.06149.05
Investing Cash Flow
-239.07-188.9937.67-29.56-8.08128.64

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
48.840.7517.253.73.425.89
Repurchase of Common Stock
-11.06-7.73-4.98-2.21-0.9-
Financing Cash Flow
37.7433.0212.271.52.525.89

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-16.36-17.9975.63-14.760.258.22

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
182.84136.4225.4113.175.7-126.71
Free Cash Flow Growth
174.98%436.82%92.94%130.99%--
Free Cash Flow Margin
21.74%20.13%6.00%4.87%2.59%-328.75%
Free Cash Flow Per Share
2.231.730.360.180.08-1.85
Levered Free Cash Flow
126.1497.8922.5713.79-2.36-83.56
Unlevered Free Cash Flow
126.1497.8922.5713.79-2.36-83.56

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
0.013.0125.6110.691.28
Change in Working Capital
41.0424.7924.811.35-22.580.69
SEC Filings: 10-K · 10-Q